Paul P. Hung

1.1k total citations
30 papers, 857 citations indexed

About

Paul P. Hung is a scholar working on Genetics, Epidemiology and Infectious Diseases. According to data from OpenAlex, Paul P. Hung has authored 30 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Paul P. Hung's work include Virus-based gene therapy research (13 papers), Viral gastroenteritis research and epidemiology (8 papers) and HIV Research and Treatment (6 papers). Paul P. Hung is often cited by papers focused on Virus-based gene therapy research (13 papers), Viral gastroenteritis research and epidemiology (8 papers) and HIV Research and Treatment (6 papers). Paul P. Hung collaborates with scholars based in Canada, United States and United Kingdom. Paul P. Hung's co-authors include Alan R. Davis, Satoshi Mizutani, Michael D. Lubeck, Brian R. Murphy, Harriet L. Robinson, William H. Robinson, Robert M. Chanock, Peter L. Collins, Surendra K. Dheer and Murty Chengalvala and has published in prestigious journals such as Nature Biotechnology, Biochemistry and Journal of Virology.

In The Last Decade

Paul P. Hung

30 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul P. Hung Canada 16 416 313 305 245 125 30 857
A. C. R. Samson United Kingdom 18 721 1.7× 258 0.8× 260 0.9× 167 0.7× 62 0.5× 34 945
Mark S. Galinski United States 20 740 1.8× 262 0.8× 355 1.2× 184 0.8× 68 0.5× 33 1.0k
Frances J. Palmer‐Hill United States 8 878 2.1× 240 0.8× 217 0.7× 325 1.3× 366 2.9× 8 1.3k
Kenneth Dimock Canada 23 565 1.4× 242 0.8× 419 1.4× 387 1.6× 110 0.9× 43 1.2k
Gaie Brown United Kingdom 16 630 1.5× 140 0.4× 290 1.0× 255 1.0× 110 0.9× 23 890
Alfred M. Del Vecchio United States 13 333 0.8× 97 0.3× 238 0.8× 181 0.7× 90 0.7× 18 770
E. Dale Lehman United States 11 426 1.0× 222 0.7× 269 0.9× 242 1.0× 242 1.9× 15 940
Fernando de Noronha United States 14 288 0.7× 274 0.9× 161 0.5× 101 0.4× 211 1.7× 33 737
Brigitte Sigrist Switzerland 13 200 0.5× 192 0.6× 118 0.4× 254 1.0× 129 1.0× 24 753
V. Juillard France 17 171 0.4× 323 1.0× 234 0.8× 284 1.2× 245 2.0× 21 875

Countries citing papers authored by Paul P. Hung

Since Specialization
Citations

This map shows the geographic impact of Paul P. Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul P. Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul P. Hung more than expected).

Fields of papers citing papers by Paul P. Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul P. Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul P. Hung. The network helps show where Paul P. Hung may publish in the future.

Co-authorship network of co-authors of Paul P. Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Paul P. Hung. A scholar is included among the top collaborators of Paul P. Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul P. Hung. Paul P. Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lubeck, Michael D., Robert J. Natuk, Murty Chengalvala, et al.. (1994). Immunogenicity of Recombinant Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees Following Intranasal Administration. AIDS Research and Human Retroviruses. 10(11). 1443–1449. 64 indexed citations
2.
Dheer, Surendra K., et al.. (1994). Isolation and characterization of adenovirus-associated VA RNAs of human adenovirus type 7. Gene. 142(2). 309–310. 1 indexed citations
3.
Lubeck, Michael D., Bheem M. Bhat, Ramesh A. Bhat, et al.. (1994). Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model. Vaccine. 12(7). 607–612. 39 indexed citations
4.
Kalyan, Narender K., Michael Pisano, Wah-Tung Hum, et al.. (1994). Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1. Vaccine. 12(8). 753–760. 23 indexed citations
5.
Bhat, Ramesh A., Shi-Mao Xia, Wah-Tung Hum, et al.. (1994). Substrate Specificity of the NS3 Serine Proteinase of Hepatitis C Virus as Determined by Mutagenesis at the NS3/NS4A Junction. Virology. 204(1). 163–169. 27 indexed citations
6.
Hung, Paul P., et al.. (1994). Relevance of the guinea-pig necrotic inflammation footpad reaction to safety concerns with MDP-based adjuvants. Vaccine. 12(8). 687–690. 1 indexed citations
7.
Natuk, Robert J., Michael D. Lubeck, Pranab K. Chanda, et al.. (1993). Immunogenicity of Recombinant Human Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees. AIDS Research and Human Retroviruses. 9(5). 395–404. 56 indexed citations
8.
Lubeck, Michael D., Alan R. Davis, Ramesh A. Bhat, et al.. (1992). Immunogenicity of Recombinant Adenovirus-Respiratory Syncytial Virus Vaccines with Adenovirus Types 4, 5, and 7 Vectors in Dogs and a Chimpanzee. The Journal of Infectious Diseases. 166(4). 769–775. 61 indexed citations
9.
10.
Tacket, Carol O., Genevieve A. Losonsky, Michael D. Lubeck, et al.. (1992). Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. Vaccine. 10(10). 673–676. 43 indexed citations
11.
Chengalvala, Murty, Michael D. Lubeck, Robert J. Natuk, et al.. (1991). Adenovirus vectors for gene expression. Current Opinion in Biotechnology. 2(5). 718–722. 14 indexed citations
12.
Chengalvala, Murty, et al.. (1991). Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Vaccine. 9(7). 485–490. 33 indexed citations
13.
Hung, Paul P., et al.. (1991). Growth of Transformed C-127 Cell in Bioreactors for Large-Scale t-PA Production. Nature Biotechnology. 9(9). 805–808. 7 indexed citations
14.
Chanda, Pranab K., Robert J. Natuk, Surendra K. Dheer, et al.. (1990). Helper Independent Recombinant Adenovirus Vectors: Expression of HIV env or HBV Surface Antigen. International Reviews of Immunology. 7(1). 67–77. 6 indexed citations
15.
Mason, B B, Alan R. Davis, Murty Chengalvala, et al.. (1990). Adenovirus vaccine vectors expressing hepatitis B surface antigen: Importance of regulatory elements in the adenovirus major late intron. Virology. 177(2). 452–461. 31 indexed citations
16.
Kalyan, Narender K., et al.. (1990). Alterations in the Domain Structure of Tissue-Type Plasminogen Activator Change the Nature of Asparagine-Linked Glycosylation. Nature Biotechnology. 8(4). 321–325. 17 indexed citations
17.
18.
Wang, Lin‐Fa, Sui‐Lam Wong, Narender K. Kalyan, et al.. (1988). Expression and secretion of human atrial natriuretic α-factor in Bacillus subtilis using the subtilisin signal peptide. Gene. 69(1). 39–47. 24 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. C. R. Samson Breakdown of academic impact, for papers by Mark S. Galinski Breakdown of academic impact, for papers by Frances J. Palmer‐Hill Breakdown of academic impact, for papers by Kenneth Dimock Breakdown of academic impact, for papers by Gaie Brown Breakdown of academic impact, for papers by Alfred M. Del Vecchio Breakdown of academic impact, for papers by E. Dale Lehman Breakdown of academic impact, for papers by Fernando de Noronha Breakdown of academic impact, for papers by Brigitte Sigrist Breakdown of academic impact, for papers by V. Juillard
Rankless by CCL
2026